RT Journal Article
SR Electronic
T1 Genomic epidemiology of COVID-19 in care homes in the East of England
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.26.20182279
DO 10.1101/2020.08.26.20182279
A1 Hamilton, William L.
A1 Tonkin-Hill, Gerry
A1 Smith, Emily
A1 Aggarwal, Dinesh
A1 Houldcroft, Charlotte J.
A1 Warne, Ben
A1 Brown, Colin S.
A1 Meredith, Luke W.
A1 Hosmillo, Myra
A1 Jahun, Aminu S.
A1 Curran, Martin D.
A1 Parmar, Surendra
A1 Caller, Laura G.
A1 Caddy, Sarah L.
A1 Khokhar, Fahad A.
A1 Yakovleva, Anna
A1 Hall, Grant
A1 Feltwell, Theresa
A1 Pinckert, Malte L.
A1 Georgana, Iliana
A1 Chaudhry, Yasmin
A1 Brown, Nicholas M.
A1 Gonçalves, Sónia
A1 Amato, Roberto
A1 Harrison, Ewan M.
A1 Beale, Mathew A.
A1 Chapman, Michael Spencer
A1 Jackson, David K.
A1 Johnston, Ian
A1 Alderton, Alex
A1 Sillitoe, John
A1 Langford, Cordelia
A1 Dougan, Gordon
A1 Peacock, Sharon J.
A1 Kwiatkowski, Dominic P.
A1 Goodfellow, Ian
A1 Török, M. Estée
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/01/25/2020.08.26.20182279.abstract
AB COVID-19 poses a major challenge to care homes, as SARS-CoV-2 is readily transmitted and causes disproportionately severe disease in older people. Here, 1,167 residents from 337 care homes were identified from a dataset of 6,600 COVID-19 cases from the East of England. Older age and being a care home resident were associated with increased mortality. SARS-CoV-2 genomes were available for 700 residents from 292 care homes. By integrating genomic and temporal data, 409 viral clusters within the 292 homes were identified, indicating two different patterns - outbreaks among care home residents and independent introductions with limited onward transmission. Approximately 70% of residents in the genomic analysis were admitted to hospital during the study, providing extensive opportunities for transmission between care homes and hospitals. Limiting viral transmission within care homes should be a key target for infection control to reduce COVID-19 mortality in this population.Impact statement SARS-CoV-2 can spread efficiently within care homes causing COVID-19 outbreaks among residents, who are at increased risk of severe disease, emphasising the importance of stringent infection control in this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by COG-UK (supported by the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute); the Wellcome Trust; the Academy of Medical Sciences; the Health Foundation; and the Cambridge NIHR Biomedical Research Centre. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted as part of surveillance for COVID-19 infections under the auspices of Section 251 of the NHS Act 2006. It therefore did not require individual patient consent or ethical approval. The COG-UK study protocol was approved by the Public Health England Research Ethics Governance Group (reference: R&D NR0195).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe genome sequence data and limited metadata are available through the COVID-19 Genomics Consortium UK (COG-UK) and GISAID websites. https://www.cogconsortium.uk/data/ https://www.gisaid.org/